Nexentis Technologies Inc. (NXTS)
Nexentis Technologies Inc. operates in the Agricultural Inputs industry of the Basic Materials sector, headquartered in Ness Ziona, TA, IL. The stock last traded at $1.41, up 2.17% on the session, giving a market capitalisation of $79,799. On trailing twelve-month figures it carries a trailing P/E of -0.07, a net margin of 24283.3%. Its beta of 1.87 implies it has historically moved more than the broad market.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.